OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized Trials Meeting Abstract

publication date

  • July 1, 2022

webpage

published in

keywords

  • Incontinence
  • Male
  • Overactive bladder

start page

  • S44

end page

  • S44

volume

  • 214